An Invokana lawsuit was filed by a man from Mississippi alleging that the side effects of this antidiabetic drug resulted in the surgery to have his leg amputated and also caused kidney failure, diabetic ketoacidosis, and sepsis. The complaint was filed in the U.S. District Court for the District of New Jersey against Johnson & Johnson and its Janssen Pharmaceuticals alleging that the manufacturers failed to adequately warn the users and medical community about the risks, withheld information about the link between Invokana and amputations.
Another Invokana lawsuit was filed by a man from Florida who had to amputate his second right toe due to ongoing ulceration and osteomyelitis, leaving him permanently disfigured. This was less than a year after he was first prescribed Invokana for treatment of type 2 diabetes. This case too shall soon join the Invokana lawsuits pending in the New Jersey federal court.
Another renal failure lawsuit was filed in the U.S. District Court for the District of New Jersey by a man who claims the side effects of Invokana resulted in his diagnosis of renal failure, requiring hospitalization and substantial medical treatment.
A kidney failure lawsuit linked to the use of Invokana was filed by a North Carolina woman who had to undergo hospitalization and a considerable medical treatment. She is holding the makers of Invokana responsible for her injuries.
Invokana: MDL 2750, in re: Invokana (Canagliflozin) Products Liability Litigation) was created in December 2016, presided over by Hon. Brian R. Martinotti, in the U.S. District Court for the District of New Jersey; the first bellwether is scheduled for September 2018. Cases are also filed in state courts, primarily in California, Pennsylvania, and New Jersey. There are more than 1,000 Invokana lawsuits currently pending the federal MDL and are in the pretrial discovery phase.